Glaxo Pays $2.5 Million In Paxil Case
Jury members in Philadelphia have ordered GlaxoSmithKline to pay $2.5 million to a woman who was prescribed Paxil (an antidepressant drug) that caused birth defects to her 3-year-old son. In a study performed by GlaxoSmithKline, researchers found that pregnant women who were taking Paxil were at a greater risk of birth defects in their children. GlaxoSmithKline was found guilty even though the FDA issued warnings about the drug stating that it may cause birth defects in children. Punitive damages were not given to the plaintiff. The company has made arrangements to appeal the ruling.
– Source: Associated Press and Lawyers USA Online